N/A
N=50
Acceptance and Commitment Therapy for Chronic Pain in Cancer Survivors
Chronic Pain
Bottom Line
View on ClinicalTrials.gov: NCT03661840 ↗Enrolled (actual)
50
Serious AEs
0.0%
Results posted
Jan 2024
Primary outcome: Primary: The Degree of Effectiveness of Acceptance and Commitment Therapy: [Impact] — 23.9; 21.4; 41.7; 37.5 units on a scale — p=0.82
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Acceptance and Commitment Therapy (Behavioral); Treatment as Usual (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Colorado, Denver
- Primary completion
- Mar 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY The Degree of Effectiveness of Acceptance and Commitment Therapy: [Impact] |
62.6; 74.1; 73.9; 72.9 | 0.06 |
| PRIMARY The Degree of Effectiveness of Acceptance and Commitment Therapy: [Impact] |
62.6; 74.1; 73.9; 72.9 | 0.06 |
| SECONDARY Number of Participants Who Want to Use Acceptance and Commitment Therapy as a Method for Treating Chronic Pain Post Active Cancer Treatment Active Cancer Treatment |
19; 19; 18; 18; 14; 18 | — |
| SECONDARY The Degree to Which Patients Enjoy Using Acceptance and Commitment Therapy as a Method for Treating Chronic Pain Post Active Cancer Treatment: [Acceptability] |
4.4; 4.5; 4.6; 4.6; 4.6; 4.6 | — |
| SECONDARY The Ability of Methodological Strategies Used to Monitor and Enhance the Reliability and Validity of ACT: [Fidelity] |
100; 100; 100; 100; 100; 100 | — |
Summary
A study to help manage chronic pain in cancer survivors through Acceptance and Commitment Therapy (ACT) after undergoing active cancer treatment, such as surgery, chemotherapy, and/or radiation.
Eligibility Criteria
Inclusion Criteria
- Provision to sign and date the consent form
- Stated willingness to comply with all study procedures and be available for the duration of the study
- Be a male or female aged 18-100
- Have pathology confirmed diagnosis of a solid tumor cancer
- Be three or more months out from active cancer treatment (surgery, chemotherapy, and/or radiation)
- Endorses experiencing pain for three or more months prior to eligibility screening
- Indicates moderate to severe difficulties with pain interference as related to their cancer experience, with a score of 4 or higher on the pain interference item from the Chronic Pain Grading Questionnaire
- Shows no evidence of cancer disease (NED) or with stable, chronic disease under "watchful waiting"
- Fluent in English
- Psychiatric stability as assessed by chart review and study personnel (e.g., not exhibiting symptoms consistent with diagnoses of serious mental illness such as active psychosis or mania)
Exclusion Criteria
- Having pain that can be solely attributed to a diagnosis outside of their cancer experience
- Presenting with barriers to group participation (e.g., social anxiety) or when group-based provision of care would impede participant's treatment or that of other group members
- Patients with a diagnosis of malignant neoplasm of the brain (ICD-10 C71) or malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system (ICD-10 C72).
Data sourced from ClinicalTrials.gov (NCT03661840). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.